Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastro-TIR: Domperidone in Type 1 Diabetes with Delayed Gastric Emptying
NCT06695962Phase 3Not yet recruiting
- Sponsor
- Rouen University Hospital
- Start
- Mar 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of domperidone in type 1 diabetes mellitus (T1D) and gastroparesis (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Time in Range at 14 days. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
domperidone
03
Conditions
type 1 diabetes mellitus (T1D)gastroparesis
Beyond the preview
Go deeper on NCT06695962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06695962.